Fu-Xu Wang Selected Research

Fu-Xu Wang Research Topics

Disease

6	Leukemia 10/2014 - 04/2004
4	Lymphoma (Lymphomas) 04/2021 - 08/2002
3	B-Cell Lymphoma (Lymphoma, B Cell) 04/2021 - 12/2006
3	Neoplasms (Cancer) 01/2019 - 06/2004
2	Residual Neoplasm 01/2019 - 12/2003
2	T-Cell Lymphoma (Lymphoma, T Cell) 08/2007 - 06/2005
2	Multiple Myeloma 06/2007 - 06/2004
1	Hematologic Neoplasms (Hematological Malignancy) 08/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2020
1	Mucositis 01/2019
1	Hypoproteinemia 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Primary Myelofibrosis (Myelosclerosis) 06/2007
1	Disease Progression 06/2007
1	Rare Diseases (Rare Disease) 06/2007
1	Necrosis 06/2007
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 06/2005
1	Acute Promyelocytic Leukemia 12/2003

Drug/Important Bio-Agent (IBA)

2	Single-Chain AntibodiesIBA 12/2009 - 12/2006
2	VaccinesIBA 12/2009 - 12/2006
2	Aligeron (AS 2)IBA 10/2008 - 12/2003
2	Arsenic Trioxide (Trisenox)FDA Link 10/2008 - 12/2003
2	Non-Receptor Type 6 Protein Tyrosine PhosphataseIBA 10/2006 - 04/2004
2	DNA (Deoxyribonucleic Acid)IBA 06/2004 - 08/2002
1	HLA Antigens (Human Leukocyte Antigens)IBA 08/2022
1	Therapeutic UsesIBA 08/2022
1	Immune Checkpoint InhibitorsIBA 04/2021
1	Chimeric Antigen ReceptorsIBA 04/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	Caspase 9IBA 10/2014
1	Caspase 3 (Caspase-3)IBA 10/2014
1	enhanced green fluorescent proteinIBA 12/2009
1	Chemokine CCL7IBA 12/2009
1	AntigensIBA 12/2009
1	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 12/2009
1	DNA VaccinesIBA 12/2009
1	CytokinesIBA 12/2009
1	TransferasesIBA 04/2009
1	TNF-Related Apoptosis-Inducing LigandIBA 10/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2008
1	Immunoglobulin D (IgD)IBA 06/2007
1	Proteins (Proteins, Gene)FDA Link 12/2006
1	Daunorubicin (Cerubidine)FDA LinkGeneric 12/2006
1	Messenger RNA (mRNA)IBA 10/2006
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2006
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 06/2005
1	Granzymes (Granzyme)IBA 06/2005
1	mevastatin (CS 500)IBA 06/2004
1	Coenzyme A (CoA)IBA 06/2004
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2004
1	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 12/2003
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2003
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 02/2003
1	SodiumIBA 08/2002
1	Protein Tyrosine PhosphatasesIBA 08/2002
1	Vanadates (Orthovanadate)IBA 08/2002

Therapy/Procedure

3	Hematopoietic Stem Cell Transplantation 08/2022 - 01/2019
3	Therapeutics 04/2021 - 12/2003
2	Transplantation 08/2022 - 01/2019
1	Haploidentical Transplantation 08/2022
1	Drug Therapy (Chemotherapy) 08/2007